Literature DB >> 12209952

In vivo drug distribution dynamics in thermoablated and normal rabbit livers from biodegradable polymers.

Jinming Gao1, Feng Qian, Agata Szymanski-Exner, Nicholas Stowe, John Haaga.   

Abstract

Image-guided radiofrequency ablation combined with intratumoral drug delivery provides a novel and minimally invasive treatment of liver cancers. In this study, the in vivo transport properties of doxorubicin in thermoablated and nonablated rabbit livers were characterized and compared. Doxorubicin was released from polymer implants (millirods) to the ablated and nonablated liver tissue. At different time points, the 2D distribution profiles were quantitatively determined by a fluorescence imaging method. Analysis of the doxorubicin concentration at the ablation boundary showed that it reached a maximum of 49.8 microg/g at 24 h after implantation, which was higher than the reported cytotoxic concentration of doxorubicin (6.4 microg/g) for liver VX-2 cancer cells. This value dropped to 0.4 microg/g at 48 h after implantation due to the depletion of doxorubicin from the polymer millirod. Results also showed that the area of drug distribution was significantly larger in ablated tissue than nonablated tissue. The therapeutic penetration distance was found to be 5.2 mm in thermoablated livers, compared to 1.2 mm in nonablated livers at 24 h. This difference in drug transport properties is attributed to destruction of the vasculature network in the ablated tissue as supported by histological analysis. Consequently, drug washout by blood perfusion is hampered while drug diffusion becomes the dominant process of transport in the ablated tissue. Results from this study provide insightful information on the rational design and development of polymer millirods for intratumoral drug delivery applications. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209952     DOI: 10.1002/jbm.10292

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  8 in total

1.  Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors.

Authors:  Brent D Weinberg; Ravi B Patel; Agata A Exner; Gerald M Saidel; Jinming Gao
Journal:  J Control Release       Date:  2007-08-25       Impact factor: 9.776

2.  Species and density of implant surface chemistry affect the extent of foreign body reactions.

Authors:  Ashwin Nair; Ling Zou; Dhiman Bhattacharyya; Richard B Timmons; Liping Tang
Journal:  Langmuir       Date:  2008-01-12       Impact factor: 3.882

Review 3.  Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers.

Authors:  Jesse B Wolinsky; Yolonda L Colson; Mark W Grinstaff
Journal:  J Control Release       Date:  2011-12-01       Impact factor: 9.776

Review 4.  Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma.

Authors:  Anne Hulin; Jeanick Stocco; Mohamed Bouattour
Journal:  Clin Pharmacokinet       Date:  2019-08       Impact factor: 6.447

Review 5.  Biomedical Imaging in Implantable Drug Delivery Systems.

Authors:  Haoyan Zhou; Christopher Hernandez; Monika Goss; Anna Gawlik; Agata A Exner
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

6.  Comparison of doxorubicin concentration profiles in radiofrequency-ablated rat livers from sustained- and dual-release PLGA millirods.

Authors:  Feng Qian; Nicholas Stowe; Gerald M Saidel; Jinming Gao
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

7.  Increased Duration of Heating Boosts Local Drug Deposition during Radiofrequency Ablation in Combination with Thermally Sensitive Liposomes (ThermoDox) in a Porcine Model.

Authors:  Christine E Swenson; Dieter Haemmerich; Donald H Maul; Bridget Knox; Nicole Ehrhart; Robert A Reed
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

8.  Modelling of combination therapy using implantable anticancer drug delivery with thermal ablation in solid tumor.

Authors:  Muneer Al-Zu'bi; Ananda Mohan
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.